Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial

Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial

Introduction Erythema nodosum leprosum (ENL) is an immunological complication of leprosy. ENL results in morbidity and disability and if it is not treated can lead to death. The current treatment consists of thalidomide or high doses of oral corticosteroids for prolonged periods. Thalidomide is not...

Full description

Bibliographic Details
Main Authors: Barbara de Barros, Saba M Lambert, Mahesh Shah, Vivek V Pai, Joydeepa Darlong, Benjamin Jewel Rozario, Medhi Denisa Alinda, Anna M Sales, Shimelis Doni, Deanna A Hagge, Dilip Shrestha, M. Yulianto Listiawan, Abeba M Yitaye, Jose A C Nery, Kapil D Neupane, Vivianne L A Dias, C. Ruth Butlin, Peter G Nicholls, Diana Lockwood
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/11/e037700.full

Internet

https://bmjopen.bmj.com/content/10/11/e037700.full

Similar Items